Alzheimer's Disease Genetics Study
Indiana University · with National Institute on Aging (NIA) · NCT00064870
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 10000
- US sites recruiting
- 1
- Study start
- June 2002
- Record last updated
- September 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Conditions: Alzheimer Disease; Late Onset Alzheimer Disease; Dementia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Two living family members diagnosed with AD or other dementia with any age of onset
- Biological samples available
- Fresh blood, or
- Immortalized lymphoblastic cell lines, or
- 3-5 grams of frozen cerebral cortex; fixed samples are not accepted
Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.
Exclusion Criteria
- Does not meet inclusion criteria
- Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection
Recruiting US locations
Participants are being recruited from all over the United States
Nationwide, IN 46202
Site contact: NCRAD Study Coordinator · 800-526-2839 · alzstudy@iu.edu
Study contacts (from the official record)
- Study Coordinator · 1-800-526-2839 · alzstudy@iu.edu
Similar studies in Indiana
All neurology studies in Indiana →- RecruitingPhase 3
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
TG Therapeutics, Inc.
- Location
- Indianapolis, IN + 35 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Diagnosing Epilepsy To EffeCT Change
Epiminder America, Inc.
- Location
- Indianapolis, IN + 21 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- Indianapolis, IN + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Zenas BioPharma (USA), LLC
- Location
- Indianapolis, IN + 24 other US sites
- Eligibility basics
- Ages 18–60